About this Journal Submit a Manuscript Table of Contents

Ocular Adnexal Inflammatory Diseases and Tumors

Call for Papers

The best treatment and management of ocular adnexal inflammatory diseases and tumors have not been definitively determined. There are several reasons for this. First, ocular adnexal tumors consist of a variety of benign and malignant tumors, and some can lead to tumor-related death. Second, ocular adnexal inflammatory diseases have a variety of pathogenic mechanisms, and the characteristics of each type of disease have not been sufficiently determined to allow physicians to make their differential diagnosis. And third, ocular adnexal inflammatory diseases and tumors occupy a small orbital space and can be manifested by proptosis, diplopia, ocular motility restrictions, and visual acuity disturbances.

We invite papers related to ocular adnexal inflammatory diseases and tumors. We invite investigators to contribute original research articles as well as review articles that will stimulate the differential diagnosis, clinical manifestations, and management of ocular adnexal inflammatory diseases and tumors.

We are particularly interested in articles describing idiopathic orbital inflammation, IgG4-related ophthalmic disease, and ocular adnexal marginal zone B-cell lymphoma. These inflammatory and lymphoproliferative diseases are morphologically similar and may overlap. Although recent laboratory tests, immunohistochemistry, and molecular genetic analysis have advanced their diagnosis, the etiology and pathophysiology of each are still controversial, and their managements have not been well determined. Potential topics include, but are not limited to:

  • Ocular adnexal lymphoproliferative diseases
  • Idiopathic orbital inflammation
  • IgG4-related ophthalmic disease
  • Ocular adnexal proliferative lesions
  • Orbital infectious diseases
  • Orbital tumors

Before submission authors should carefully read over the journal’s Author Guidelines, which are located at http://www.hindawi.com/journals/joph/guidelines/. Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at http://mts.hindawi.com/submit/journals/joph/oaid/ according to the following timetable:

Manuscript DueFriday, 25 April 2014
First Round of ReviewsFriday, 18 July 2014
Publication DateFriday, 12 September 2014

Lead Guest Editor

  • Toshinobu Kubota, Department of Ophthalmology, National Hospital Organization, Nagoya Medical Center, Nagoya, Japan

Guest Editors

  • Yoon-Duck Kim, Department of Ophthalmology, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea
  • Seah Lay Leng, Singapore National Eye Center and Singapore Eye Research Institute, Singapore